Going home same day vs staying overnight after afib ablation
Part of Heart & circulation clinical trials.
This trial compares whether it is safe to go home a few hours after a heart procedure for atrial fibrillation (afib) versus staying in the hospital overnight. It will help doctors understand which approach is better for your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a planned catheter ablation to treat atrial fibrillation (afib).
- The doctor will use 1 or 2 small tubes (catheters) placed in a vein in your groin.
- You do not have an active infection or skin inflammation near your groin.
- Your platelet count is above 50,000 cells per cubic millimeter.
- Your body mass index (BMI) is between 18 and 45.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies different surgical techniques for treating atrial fibrillation during heart surgery. It may help people with a history of AFib who are already scheduled for open-heart surgery.
This trial looks at whether a special heart rhythm treatment called “ablation” works well when done during certain heart operations. It may help reduce atrial fibrillation (AF) symptoms or future abnormal rhythm episodes for people who are already having surgery.
This study compares three approaches to treat persistent atrial fibrillation (AF) that lasts more than 7 days. It tests whether isolating the pulmonary veins alone is enough, or if also targeting low-voltage areas (scarred heart tissue) during either normal rhythm or AF works better.
This study follows adults who have had a procedure to treat an irregular heartbeat, to understand who is more likely to have it return. It may help doctors predict risk and plan follow-up after the procedure.
This study tests whether doing a common AFib procedure (radiofrequency ablation) is safe and effective at the same time as closing off the left atrial appendage with the WATCHMAN FLX device. It's for people with nonvalvular atrial fibrillation who are already candidates for both treatments.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.